Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Regen BioPharma Inc RGBP

Regen BioPharma Inc. is a biotechnology company. The Company is engaged on the immunology and immunotherapy space. The Company is focused on novel technologies through pre-clinical and Phase I/ II clinical trials. It is involved on mRNA and small molecule therapies for treating cancer and autoimmune disorders. It is also developing products treating blood disorders using small molecules and... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (OTCPK:RGBP)

Regen BioPharma, Inc. to Discuss Plans to Move Forward with HemaXellerate into Clinical Phase 1 at the Emerging Growth Conference on April 4, 2024

PR Newswire April 2, 2024

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024

PR Newswire March 5, 2024

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on February 7, 2024

PR Newswire February 5, 2024

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on January 10, 2024

PR Newswire January 8, 2024

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on December 7, 2023

PR Newswire December 5, 2023

Regen BioPharma, Inc. Selects Contract Research Organization to Assist in DuraCAR Experiments

PR Newswire November 16, 2023

Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Program

PR Newswire November 14, 2023

Regen BioPharma, Inc. to Discuss Confirmation Study Results on Its DuraCar Program at the Emerging Growth Conference on November 1, 2023

PR Newswire October 30, 2023

Regen BioPharma, Inc. Receives Second Phase Confirmatory Data on its Duracar CAR-T Cell Therapy Program

PR Newswire October 25, 2023
View More News ››

Opinion & Analysis (OTCPK:RGBP)

No current opinion is available.
View More Opinion ››

Bullboard Posts (OTCPK:RGBP)

Presenting on the Emerging Growth Conference 67 Day 1 on Feb

BREAKING NEWS: $RGBP Presenting on the Emerging Growth Conference 67 Day 1 on February 7 Register NowMIAMI, Feb. 06, 2024 (GLOBE...
whytestocks - February 6, 2024

Regen BioPharma, Inc. to Present at the Emerging Growth Conf

Regen BioPharma, Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time...
averagepennies - December 5, 2023

Regen BioPharma, Inc. Selects Contract Research Organization

SAN DIEGO, Nov. 16, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) The Company has...
averagepennies - November 16, 2023

Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Pro

SAN DIEGO, Nov. 14, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has previously...
averagepennies - November 14, 2023

Regen BioPharma, Inc. CEO Outlines Future Steps in CAR T Pro

SAN DIEGO, Nov. 14, 2023 SAN DIEGO, Nov. 14, 2023 /PRNewswire/ -- Regen BioPharma, Inc. (OTC PINK: RGBP) (OTC PINK: RGBPP) has...
Tdogzz18 - November 14, 2023

Emerging Growth Conference Regen BioPharma Inc. $RGBP

<< View Post To Watch Video >>
stockpickmover1 - November 14, 2023
View more Bullboard ››

International Lithium Corp.

International Lithium Corp.

International Lithium Corp has lithium exploration properties located in Canada and Ireland. Its primary strategic focus is ...
View More »